Pynazolam

Last updated
Pynazolam
Pynazolam structure.png
Identifiers
  • 1-methyl-8-nitro-6-(pyridin-2-yl)-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine
CAS Number
PubChem CID
ChemSpider
Chemical and physical data
Formula C16H12N6O2
Molar mass 320.312 g·mol−1
3D model (JSmol)
  • CC1=NN=C2N1C3=C(C=C(C=C3)[N+](=O)[O-])C(=NC2)C4=CC=CC=N4
  • InChI=1S/C16H12N6O2/c1-10-19-20-15-9-18-16(13-4-2-3-7-17-13)12-8-11(22(23)24)5-6-14(12)21(10)15/h2-8H,9H2,1H3
  • Key:TULLJLNDPPOHKC-UHFFFAOYSA-N

Pynazolam is a triazolobenzodiazepine derivative which has been sold online as a designer drug. It was first described in the 1970s by a team led by Leo Sternbach, [1] but it was never marketed.

In silico studies suggest it has relatively potent hypnotic and sedative effects. [2] Further research is limited, and thus very little is known about the drug's pharmacological properties.

See also

References

  1. US 3970664,Sternbach LH, Walser A,"Preparation of triazolo benzodiazepines.",issued 20 July 1976, assigned to Hoffmann-LaRoche, Inc.
  2. Catalani V, Floresta G, Botha M, Corkery JM, Guirguis A, Vento A, et al. (January 2023). "In silico studies on recreational drugs: 3D quantitative structure activity relationship prediction of classified and de novo designer benzodiazepines". Chemical Biology & Drug Design. 101 (1): 40–51. doi:10.1111/cbdd.14119. hdl: 2299/25749 . PMID   35838189.